Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs.
暂无分享,去创建一个
W. Ageno | S. Testa | D. Poli | A. Falanga | E. Antonucci | G. Palareti | D. Barcellona | P. Simioni | V. Pengo | P. Pignatelli | A. Ciampa | E. Vignini | L. Martinese | L. Masciocco | C. Paparo | P. Chiarugi
[1] M. Humbert,et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .
[2] G. Lip,et al. Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage , 2019, Stroke.
[3] H. Huttner,et al. Management of oral anticoagulation after intracerebral hemorrhage , 2019, International journal of stroke : official journal of the International Stroke Society.
[4] G. Lip,et al. Anticoagulation Resumption After Intracerebral Hemorrhage , 2018, Current Atherosclerosis Reports.
[5] P. Heuschmann,et al. Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation , 2017, Neurology.
[6] F. Skjøth,et al. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation , 2017, JAMA internal medicine.
[7] J. Uhm,et al. Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage. , 2016, Heart rhythm.
[8] A. Brandes,et al. Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage , 2016, Stroke.
[9] T. Chao,et al. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage , 2016, Circulation.
[10] W. Ageno,et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage. , 2015, Thrombosis research.
[11] G. Lip,et al. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study , 2015, Circulation.
[12] C. Anderson,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.
[13] N. Magrini,et al. The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation , 2015, PloS one.
[14] G. Fink,et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. , 2015, JAMA.
[15] H. Büller,et al. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. , 2014, Blood.
[16] F. Dentali,et al. Recurrence of ICH after resumption of anticoagulation with VK antagonists , 2014, Neurology.
[17] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.
[18] Gerhard Hindricks,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[19] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.
[20] Yutao Guo,et al. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. , 2012, Journal of the American College of Cardiology.
[21] M. O’Donnell,et al. Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation? , 2012, Stroke.
[22] C. Anderson,et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.
[23] D Bergqvist,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.
[24] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.